Business · 27/08/1999

FDA Guidance on Dioxin/PCB Contamination in Drugs and Biological Products

The Food and Drug Administration (FDA) has released a guidance document advising the pharmaceutical industry on how to identify possible contamination of drugs and biological products with dioxins and polychlorinated biphenyls (PCBs), which were introduced in animal feed in several European Union countries in 1999. Manufacturers must verify the origin of their materials or conduct testing to ensure their products are safe.